Your browser is no longer supported. Please, upgrade your browser.
Settings
CBM Cambrex Corporation daily Stock Chart
CBM [NYSE]
Cambrex Corporation
Index- P/E13.91 EPS (ttm)2.71 Insider Own0.40% Shs Outstand33.58M Perf Week-4.41%
Market Cap1.27B Forward P/E16.29 EPS next Y2.31 Insider Trans-38.62% Shs Float33.05M Perf Month-11.36%
Income91.30M PEG0.93 EPS next Q0.44 Inst Own- Short Float15.33% Perf Quarter-19.98%
Sales532.10M P/S2.38 EPS this Y-12.60% Inst Trans1.25% Short Ratio12.00 Perf Half Y-38.68%
Book/sh19.47 P/B1.94 EPS next Y2.98% ROA9.00% Target Price55.00 Perf Year-29.57%
Cash/sh2.86 P/C13.19 EPS next 5Y15.00% ROE14.60% 52W Range33.80 - 69.43 Perf YTD-0.21%
Dividend- P/FCF51.86 EPS past 5Y22.60% ROI8.70% 52W High-45.73% Beta2.44
Dividend %- Quick Ratio2.90 Sales past 5Y10.80% Gross Margin37.00% 52W Low11.48% ATR2.13
Employees1732 Current Ratio3.90 Sales Q/Q-26.30% Oper. Margin19.10% RSI (14)38.82 Volatility6.85% 4.22%
OptionableYes Debt/Eq0.46 EPS Q/Q-96.40% Profit Margin17.40% Rel Volume2.71 Prev Close35.80
ShortableYes LT Debt/Eq0.46 EarningsFeb 13 BMO Payout0.00% Avg Volume422.32K Price37.68
Recom1.20 SMA20-10.01% SMA50-10.35% SMA200-27.91% Volume1,145,714 Change5.25%
Nov-09-18Upgrade First Analysis Sec Outperform → Strong Buy $73 → $63
Sep-25-18Initiated Jefferies Buy $75.50
Feb-14-18Downgrade Longbow Buy → Neutral
Jan-16-18Initiated William Blair Outperform
Jan-17-17Reiterated First Analysis Sec Overweight $54 → $66
Nov-07-16Upgrade First Analysis Sec Equal-Weight → Overweight $54
Feb-11-16Reiterated Singular Research Buy $63 → $60
Feb-01-16Initiated Sidoti Buy
May-29-15Initiated Singular Research Buy $51
Mar-24-08Downgrade KeyBanc Capital Mkts Buy → Hold
Mar-24-08Downgrade First Analysis Sec Overweight → Equal-Weight
Nov-05-07Downgrade Longbow Buy → Neutral
Mar-12-07Upgrade KeyBanc Capital Mkts / McDonald Hold → Buy $26
Feb-17-19 08:20AM  3 Top Biotech Stocks to Buy in February Motley Fool
Feb-15-19 09:19AM  CBM Missed Earnings by Over 90% InvestorPlace +5.25%
Feb-13-19 03:58PM  Cambrex Corp (CBM) Q4 2018 Earnings Conference Call Transcript Motley Fool -12.00%
11:25AM  Why Cambrex Corporation Is Tanking Today Motley Fool
08:05AM  Cambrex (CBM) Surpasses Q4 Earnings Estimates Zacks
07:10AM  Cambrex: 4Q Earnings Snapshot Associated Press
06:40AM  Cambrex Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Feb-11-19 09:24AM  Cambrex (CBM) Upgraded to Buy: Here's What You Should Know Zacks
Feb-08-19 03:47PM  Cambrex to Announce Fourth Quarter and Full Year 2018 Financial Results on February 13, 2019 GlobeNewswire
Jan-31-19 09:30AM  CBM or ILMN: Which Is the Better Value Stock Right Now? Zacks
Jan-18-19 09:10AM  Is Cambrex (CBM) a Great Value Stock Right Now? Zacks
Jan-09-19 09:30AM  CBM or ALKS: Which Is the Better Value Stock Right Now? Zacks
Jan-08-19 11:35AM  Have Insiders Been Selling Cambrex Corporation (NYSE:CBM) Shares? Simply Wall St.
Jan-04-19 07:35AM  New Research Coverage Highlights Twenty-First Century Fox, Hill-Rom, Amphenol, Imperva, Maximus, and Cambrex Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire +6.54%
Jan-02-19 09:40AM  Cambrex Completes Acquisition of Avista Pharma Solutions GlobeNewswire
Dec-18-18 06:49AM  Hedge Funds Are Crazy About Cambrex Corporation (CBM) Insider Monkey
Dec-17-18 07:30AM  Pharmaceutical ingredient manufacturer plans expansion in High Point American City Business Journals
Dec-11-18 10:32AM  Cambrex Expands Analytical Capabilities at its High Point, NC Site GlobeNewswire
Dec-09-18 08:59AM  Interested In Cambrex Corporation (NYSE:CBM)? Heres What Its Recent Performance Looks Like Simply Wall St.
Nov-21-18 01:51AM  Edited Transcript of CBM earnings conference call or presentation 8-Nov-18 1:30pm GMT Thomson Reuters StreetEvents
Nov-20-18 01:02PM  [$$] Cambrex Buying Avista Pharma Solutions From Ampersand for $252 Million The Wall Street Journal
06:40AM  Cambrex to Acquire Avista Pharma Solutions, Adding Early Stage API and Finished Dosage Form Development & Testing Services to its Global Contract Development & Manufacturing Network GlobeNewswire
Nov-09-18 10:47AM  Cleantech Building Materials: Amendment of Loan Facility GlobeNewswire
Nov-08-18 11:57AM  Cambrex Corp (CBM) Q3 2018 Earnings Conference Call Transcript Motley Fool -10.06%
10:45AM  Cambrex (CBM) Lags Q3 Earnings and Revenue Estimates Zacks
10:14AM  What Investors Should Know About Cambrex Corporations (NYSE:CBM) Financial Strength Simply Wall St.
09:38AM  Cambrex: 3Q Earnings Snapshot Associated Press
06:40AM  Cambrex Reports Third Quarter 2018 Financial Results GlobeNewswire
Nov-05-18 03:55PM  Cambrex to Announce Third Quarter 2018 Financial Results on November 8, 2018 GlobeNewswire
08:52AM  Cambrex Corporation (NYSE:CBM): Should The Future Outlook Worry You? Simply Wall St.
Oct-30-18 05:01PM  3 Top Biotech Stocks to Buy Right Now Motley Fool
Oct-29-18 01:47PM  These Fundamentals Make Cambrex Corporation (NYSE:CBM) Truly Worth Looking At Simply Wall St.
08:15AM  Report: Developing Opportunities within Noah, 3M, Kimberly-Clark, Cambrex, Argan, and Autohome Future Expectations, Projections Moving into 2018 GlobeNewswire
Oct-08-18 08:00AM  Cambrex Invests c.$3 Million to Upgrade Generic API Manufacturing Facilities at Milan, Italy Site GlobeNewswire
07:45AM  Market Trends Toward New Normal in Ellington Financial, InfraREIT, Itron, KAR Auction Services, Cambrex, and American States Water Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Oct-01-18 11:46AM  Insmed (INSM) Wins FDA Nod for Lung Disease Drug Arikayce Zacks
Sep-25-18 11:18AM  Arena (ARNA) Posts Favorable Top-Line Data on Pain Candidate Zacks
10:25AM  Cambrex to Expand and Invest at High Point, NC Site to Create New Center of Excellence for Process Development and Clinical Supply GlobeNewswire
Sep-12-18 08:45AM  Cambrex Completes Acquisition of Halo Pharma GlobeNewswire
Aug-29-18 08:10AM  Cambrex to Present at Upcoming Investor Conferences in September GlobeNewswire
Aug-22-18 05:08AM  Cleantech Building Materials: Unaudited Interim Results to 30 June 2018 GlobeNewswire
Aug-13-18 09:45PM  Edited Transcript of CBM earnings conference call or presentation 2-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
Aug-09-18 08:05AM  Cambrex (CBM): Moving Average Crossover Alert Zacks
Aug-08-18 04:18PM  3 Top Biotech Stocks to Buy in August Motley Fool
09:30AM  CBM vs. ILMN: Which Stock Should Value Investors Buy Now? Zacks
08:53AM  BioMarin Pharmaceutical (BMRN) Catches Eye: Stock Jumps 7.9% Zacks
Aug-02-18 10:09AM  Cambrex: 2Q Earnings Snapshot Associated Press +5.42%
06:40AM  Cambrex Reports Second Quarter 2018 Financial Results GlobeNewswire
06:30AM  Cambrex Corporation to Host Earnings Call ACCESSWIRE
Jul-27-18 11:10AM  Cambrex to Announce Second Quarter 2018 Financial Results on August 2, 2018 GlobeNewswire
Jul-25-18 07:20AM  Blog Exposure - Cambrex Announces Halo Pharma Acquisition ACCESSWIRE
Jul-23-18 01:08PM  [$$] Cambrex to Buy Halo Pharma for $425 Million The Wall Street Journal
06:40AM  Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network GlobeNewswire
Jul-02-18 04:18AM  Cleantech Building Materials: China Distribution and Offtake agreement GlobeNewswire
Jun-25-18 11:50AM  Is Cambrex Corporation (NYSE:CBM) A Buy At Its Current PE Ratio? Simply Wall St.
Jun-20-18 08:10AM  New Research: Key Drivers of Growth for Winnebago Industries, SkyWest, Brightcove, Selective Insurance Group, Reinsurance Group of America, and Cambrex Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jun-12-18 08:00AM  Cambrex Expands Generic API Research and Development Capabilities at Milan, Italy Site GlobeNewswire
Jun-01-18 09:50AM  Cambrex to Present at the Jefferies 2018 Global Healthcare Conference GlobeNewswire
May-31-18 08:00AM  Cambrex Invests $5 Million in New Laboratory Expansion at its Karlskoga, Sweden Facility GlobeNewswire
May-15-18 08:00AM  Cambrex Completes Pilot Plant Expansion at its High Point, NC Facility GlobeNewswire
May-09-18 09:46AM  Edited Transcript of CBM earnings conference call or presentation 3-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-03-18 10:03AM  Cambrex: 1Q Earnings Snapshot Associated Press -10.51%
06:45AM  Cambrex Reports First Quarter 2018 Financial Results GlobeNewswire
Apr-27-18 07:35AM  Investor Expectations to Drive Momentum within Blackbaud, Pieris Pharmaceuticals, Sarepta Therapeutics, Cambrex, Stoneridge, and First Interstate BancSystem Discovering Underlying Factors of Influence GlobeNewswire
05:44AM  Cleantech Building Materials: Results of Annual General Meeting GlobeNewswire
Apr-26-18 03:15PM  Cambrex to Announce First Quarter 2018 Financial Results on May 3, 2018 GlobeNewswire
Apr-23-18 08:20AM  Cambrex Completes New $3.2 Million Analytical Research & Development Laboratory at its High Point, NC Facility GlobeNewswire
Apr-19-18 04:30PM  Cambrex Corporation to Provide Additional Information Regarding its Environmental, Social and Governance Practices GlobeNewswire
Apr-17-18 08:00AM  Cambrex Invests in New Continuous Flow Technology at its High Point, NC Facility GlobeNewswire
Apr-03-18 12:18PM  Cleantech Building Materials: Notice of AGM GlobeNewswire
Mar-29-18 06:36AM  Cleantech Building Materials: Annual Results to 31 December 2017 GlobeNewswire
Mar-19-18 03:06AM  Cleantech Building Materials: Application to Wiener Börse GlobeNewswire
Mar-16-18 07:00AM  Free Post Earnings Research Report: Cambrex Achieved Record Quarterly Revenue; EPS Climbed 4% ACCESSWIRE
06:07AM  Cleantech Building Materials: Application to Wiener Börse GlobeNewswire
Mar-15-18 09:50AM  Should Value Investors Pick Cambrex (CBM) Stock? Zacks
Feb-27-18 08:20AM  Research Report Identifies Insteel Industries, First Cash, Integra LifeSciences, Vishay Precision Group, Cambrex, and Enersys with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-20-18 10:13AM  Cleantech Building Materials: APPOINTMENT OF FINANCIAL ADVISER AND BROKER GlobeNewswire
Feb-18-18 06:00AM  3 Top Biotech Stocks to Buy in February Motley Fool
Feb-15-18 08:00AM  Cambrex to Present at the 2018 RBC Capital Markets Global Healthcare Conference GlobeNewswire
Feb-09-18 02:06PM  Edited Transcript of CBM earnings conference call or presentation 8-Feb-18 1:30pm GMT Thomson Reuters StreetEvents
07:10AM  Blog Exposure - Verastem Reported Submission of NDA For Duvelisib for Treatment of Patients with Relapsed or Refractory CLL/SLL and Follicular Lymphoma ACCESSWIRE
05:07AM  Cleantech Building Materials: Thailand Distribution and Offtake Agreement GlobeNewswire
Feb-08-18 12:32PM  Is It Time To Buy Cambrex Corporation (NYSE:CBM)? Simply Wall St.
11:38AM  Cleantech Building Materials: Amendment of Loan Facility GlobeNewswire
10:50AM  Cambrex beats 4Q profit forecasts Associated Press
06:45AM  Cambrex Reports Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
06:20AM  Cambrex Corporation to Host Earnings Call ACCESSWIRE
Feb-02-18 09:15AM  Cambrex to Announce Fourth Quarter and Full Year 2017 Financial Results on February 8, 2018 GlobeNewswire
Feb-01-18 11:49AM  Estimating The Intrinsic Value Of Cambrex Corporation (NYSE:CBM) Simply Wall St.
Jan-30-18 08:00AM  Cambrex Expands Process Research and Development Capabilities Across North America GlobeNewswire
Jan-16-18 07:00AM  Cambrex & AstraZeneca Hold Ceremony to Mark Long-Term Supply Agreement at Karlskoga, Sweden Facility GlobeNewswire
Jan-09-18 08:03AM  See what the IHS Markit Score report has to say about Cambrex Corp. Markit
Jan-01-18 07:49AM  Cambrex Corp. breached its 50 day moving average in a Bearish Manner : CBM-US : January 1, 2018 Capital Cube
Dec-27-17 03:50PM  Edited Transcript of CBM earnings conference call or presentation 7-Nov-17 1:30pm GMT Thomson Reuters StreetEvents
08:04AM  See what the IHS Markit Score report has to say about Cambrex Corp. Markit
Dec-25-17 08:05AM  See what the IHS Markit Score report has to say about Cambrex Corp. Markit
Dec-22-17 08:04AM  See what the IHS Markit Score report has to say about Cambrex Corp. Markit
Dec-21-17 08:04AM  See what the IHS Markit Score report has to say about Cambrex Corp. Markit
Dec-20-17 08:05AM  Analysis: Positioning to Benefit within Cambrex, Enersys, Esterline Technologies, Lsb Industries, Atkore International Group, and Virtusa Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Dec-11-17 07:28AM  Cambrex Corp. breached its 50 day moving average in a Bullish Manner : CBM-US : December 11, 2017 Capital Cube
Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics worldwide. Its products comprise active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products, as well as other fine chemicals. The company serves generic drug companies; and companies that discover and commercialize small molecule human therapeutics. The company sells its products directly, as well as through independent agents. Cambrex Corporation was founded in 1981 and is headquartered in East Rutherford, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KLOSK STEVEN MPresident & CEOOct 23Option Exercise17.8120,000356,200103,328Oct 24 05:21 PM
KLOSK STEVEN MPresident & CEOOct 23Sale54.7620,0001,095,25483,328Oct 24 05:21 PM
KLOSK STEVEN MPresident & CEOSep 04Option Exercise17.8155,000979,550138,328Sep 05 04:24 PM
KLOSK STEVEN MPresident & CEOSep 04Sale66.3055,0003,646,75183,328Sep 05 04:24 PM
Vadaketh Tom GeorgeEVP & CFOAug 20Option Exercise54.159,510514,9679,510Aug 21 04:18 PM
Vadaketh Tom GeorgeEVP & CFOAug 20Sale63.429,510603,0980Aug 21 04:18 PM
Cavanagh ShawnEVP & COOAug 07Option Exercise40.658,351339,46826,009Aug 07 05:53 PM
Cavanagh ShawnEVP & COOAug 07Sale62.898,351525,19417,658Aug 07 05:53 PM
Cavanagh ShawnEVP & COOAug 06Option Exercise28.6837,8991,087,08255,557Aug 07 05:53 PM
Hanley SamanthaVP, General CounselAug 06Option Exercise34.2627,500942,14427,500Aug 07 05:55 PM
KLOSK STEVEN MPresident & CEOAug 06Sale62.4580,0004,996,22583,328Aug 07 05:56 PM
Hanley SamanthaVP, General CounselAug 06Sale62.6427,5001,722,6520Aug 07 05:55 PM
Cavanagh ShawnEVP & COOAug 06Sale62.3537,8992,363,08817,658Aug 07 05:53 PM
KAUFTHAL ILANDirectorAug 06Sale62.385,500343,09054,084Aug 07 08:48 PM
KLOSK STEVEN MPresident & CEOAug 01Option Exercise16.9955,000934,300218,328Aug 02 04:34 PM
KLOSK STEVEN MPresident & CEOAug 01Sale62.4655,0003,435,248163,328Aug 02 04:34 PM
KLOSK STEVEN MPresident & CEOJul 02Option Exercise14.8855,000818,650218,328Jul 03 04:20 PM
KLOSK STEVEN MPresident & CEOJul 02Sale51.7355,0002,845,096163,328Jul 03 04:20 PM
KLOSK STEVEN MPresident & CEOJun 11Option Exercise12.4655,000685,300218,328Jun 12 09:13 PM
KLOSK STEVEN MPresident & CEOJun 11Sale45.6455,0002,510,244163,328Jun 12 09:13 PM
SARGEN GREGORYEVP, Corporate DevelopmentMay 08Sale49.4944,4982,202,15220,000May 09 04:24 PM
Cavanagh ShawnEVP & COOMay 08Sale49.5819,745979,04017,658May 09 04:21 PM
SARGEN GREGORYEVP, Corporate DevelopmentMay 07Sale49.4623,0021,137,72026,998May 09 04:24 PM
Cavanagh ShawnEVP & COOMay 07Sale49.8020,2551,008,60037,403May 09 04:21 PM